Skip to main content

Table 3 Yearly volumes of syrups and injectables, with public and private sectors market shares.

From: Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs)

country

Malawi

Rwanda

Senegal

Tanzania

Zimbabwe

Number of syrups (units)

2,750

5,500

295,000

561,000

53,500

Syrups/total adult treatments

<0.1%

0.4%

5.5%

3.7%

1%

% sales by private sector

50%

50%

84%

100%

80%

Injectables (1 day treatment equivalents)

26,000

30,000

954,000

1,000,000

16,000

% sales by private sector

60%

50%

22%

75%

100%